Jiangsu Hengrui Pharmaceuticals Co Ltd
HKEX:1276
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
HKEX:1276
|
CN |
|
Fu Shou Yuan International Group Ltd
HKEX:1448
|
CN |
|
A
|
AfreecaTV Co Ltd
KOSDAQ:067160
|
KR |
|
D
|
Dermapharm Holding SE
XBER:DMP
|
DE |
|
Rogers Communications Inc
NYSE:RCI
|
CA |
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
IN |
|
GMO Media Inc
TSE:6180
|
JP |
|
System Support Inc
TSE:4396
|
JP |
|
Lohilo Foods AB (publ)
F:66Q
|
SE |
|
A
|
Adf Group Inc
XBER:4QM
|
CA |
Wall St Price Targets
Price Targets Summary
Jiangsu Hengrui Pharmaceuticals Co Ltd
According to Wall Street analysts, the average 1-year price target for Jiangsu Hengrui Pharmaceuticals Co Ltd is 90.67 HKD with a low forecast of 77.12 HKD and a high forecast of 141.89 HKD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Jiangsu Hengrui Pharmaceuticals Co Ltd's stock price target?
Price Target
90.67
HKD
According to Wall Street analysts, the average 1-year price target for Jiangsu Hengrui Pharmaceuticals Co Ltd is 90.67 HKD with a low forecast of 77.12 HKD and a high forecast of 141.89 HKD.
What is the Revenue forecast for Jiangsu Hengrui Pharmaceuticals Co Ltd?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 11%.
What is the Gross Profit forecast for Jiangsu Hengrui Pharmaceuticals Co Ltd?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 3 years is 19%.
What is the Operating Income forecast for Jiangsu Hengrui Pharmaceuticals Co Ltd?
Projected CAGR
26%
Over the last 13 years, the compound annual growth rate for Operating Income has been 16%. The projected CAGR for the next 8 years is 26%.
What is the Pre-Tax Income forecast for Jiangsu Hengrui Pharmaceuticals Co Ltd?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 15%. The projected CAGR for the next 3 years is 22%.
What is the Net Income forecast for Jiangsu Hengrui Pharmaceuticals Co Ltd?
Projected CAGR
21%
Over the last 13 years, the compound annual growth rate for Net Income has been 16%. The projected CAGR for the next 3 years is 21%.
